RIM
TEVA icon

Redpoint Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Redpoint Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$147K Hold
18,252
– – 0.02% 571
2022
Q2 		$137K Hold
18,252
– – 0.02% 602
2022
Q1 		$171K Hold
18,252
– – 0.02% 617
2021
Q4 		$146K Hold
18,252
– – 0.01% 641
2021
Q3 		$178K Hold
18,252
– – 0.02% 641
2021
Q2 		$181K Hold
18,252
– – 0.01% 662
2021
Q1 		$211K Buy
+18,252
New +$209K 0.02% 638
2020
Q4 		– Sell
-19,695
Closed -$177K – 630
2020
Q3 		$177K Sell
19,695
-2,244
-10% -$23.7K 0.02% 561
2020
Q2 		$271K Hold
21,939
– – 0.02% 509
2020
Q1 		$197K Hold
21,939
– – 0.01% 527
2019
Q4 		$215K Hold
21,939
– – 0.01% 584
2019
Q3 		$151K Sell
21,939
-45,357
-67% -$348K 0.01% 585
2019
Q2 		$621K Hold
67,296
– – 0.03% 425
2019
Q1 		$1.05M Buy
67,296
+6,338
+10% +$112K 0.05% 376
2018
Q4 		$940K Hold
60,958
– – 0.05% 367
2018
Q3 		$1.31M Hold
60,958
– – 0.07% 334
2018
Q2 		$1.48M Hold
60,958
– – 0.08% 304
2018
Q1 		$1.04M Hold
60,958
– – 0.06% 352
2017
Q4 		$1.16M Buy
+60,958
New +$917K 0.06% 345

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Redpoint Investment Management's TEVA Position: Q3 2022 in Review

Redpoint Investment Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q3 2022 at 18,252 shares worth $147K. The position accounts for 0.02% of the portfolio, ranked #571.

Redpoint Investment Management first reported a position in TEVA in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.48M in Q2 2018. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Redpoint Investment Management held 18,252 shares of Teva Pharmaceutical Industries Limited worth $147K as of Q3 2022.
  • Redpoint Investment Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q3 2022.
  • Teva Pharmaceutical Industries Limited made up 0.02% of Redpoint Investment Management's portfolio in Q3 2022, its #571 holding.
  • Redpoint Investment Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and has held it in 19 quarters since.
  • Redpoint Investment Management's Teva Pharmaceutical Industries Limited position peaked at $1.48M in Q2 2018.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.